Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis
Table 1
Patients' basic characteristics.
Noncategorical variables
T1
T2
T3
T4
Mean
SE
Mean
SE
Mean
SE
Mean
SE
Age in years
53.9
1.1
48.6
1.6
45.4
5.3
43.4
3.9
0.019
Duration to treat in weeks
2.8
3.3
25.6
5.9
66.8
13.5
80.4
9.9
<0.001
Followup duration in weeks
61
5.6
53.6
6.9
20.5
20.2
78.7
14.3
0.035
Dialysis duration in months
49.9
5.5
49.5
7.4
31.2
21.7
44.8
15.8
0.979
Categorical variables
T1
T2
T3
T4
Gender (25 missing data)
Male
76
46.3
43
50
1
16.7
8
47.1
0.465
Female
88
60.7
43
50
5
83.3
9
52.9
Race (204 missing data)
White
41
68.3
20
76.9
2
50
3
75
African American
11
18.3
1
3.8
2
50
0
0
0.22
Others
8
13.3
5
19.2
0
0
1
25
Prior renal transplantation (2 missing data)
Prior transplantation
36
19.8
26
29.5
1
11.1
4
23.5
0.268
No prior transplantation
146
80.2
62
70.5
8
88.9
13
76.5
ESRD at diagnosis (7 missing data)
166
93.3
69
79.3
9
100
17
100
0.001
T1: patients who received no treatment other than dialysis. T2: patients who received NSF specific treatment other than renal transplantation. T3: patients who received only renal transplantation. T4: patients who received NSF specific treatment followed by renal transplantation. SE: standard error. : probability value.
